AMIX AMIX
Company Profile ↓Company Overview
AMIX (AMIX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Growth & Price Performance
Stock Price Performance
| 1 Year: | -57.00% |
| 6 Months: | +44.41% |
| 3 Months: | +52.03% |
| 1 Month: | +84.17% |
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)61.42 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 57.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Operating Income | - | - | -544.00K | -871.00K | -5.82M | -2.92M | - | -2.75M | -2.84M | -2.75M | - | -3.42M | -7.53M | -3.34M |
| Net Income | -341.00K | -448.00K | -544.00K | -865.00K | -6.04M | -3.11M | -15.43M | -2.70M | -2.81M | -2.71M | -11.41M | -3.34M | -7.45M | -3.26M |
| Diluted EPS | - | - | -0.05 | - | - | -0.23 | - | - | - | - | - | - | - | - |
| R&D Expense | - | - | 199.00K | 368.00K | 471.00K | 687.00K | - | 954.00K | 1.17M | 1.04M | - | 1.59M | 2.37M | 1.72M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -1.99M | -12.03M | -11.59M | -17.03M |
| Net Income | -1.99M | -15.43M | -11.41M | -16.71M |
| R&D Expense | 745.00K | 2.23M | 4.72M | 7.14M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 865.00K | 9.41M | 9.81M | 7.60M |
| Total Equity | 1.96M | 644.00K | 7.63M | 8.10M | 5.89M |
| Cash & Equivalents | - | 865.00K | 8.61M | 9.14M | 7.00M |
| Total Liabilities | - | 221.00K | 1.78M | 1.71M | 1.71M |
| Current Liabilities | - | 221.00K | 777.00K | 1.71M | 1.71M |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating Cash Flow | -1.85M | -6.60M | -8.26M | -12.28M |
| Investing Cash Flow | 0 | -19.00K | -14.00K | -10.00K |
| Financing Cash Flow | 675.00K | 14.41M | 8.80M | 10.16M |
| Capital Expenditure | -0 | -19.00K | -14.00K | -10.00K |
| Free Cash Flow | -1.85M | -6.62M | -8.27M | -12.29M |
Ratios (Annual)
Figures in %.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | - | - | - | - |
| ROE % | -309.0% | -202.2% | -140.9% | -283.5% |
| ROCE % | -309.0% | -139.4% | -143.1% | -289.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for AMIX
Why Autonomix Medical (AMIX) Stock Is Down Today - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNZzdEWENMbFU0aW1ibWc2a1MtS0ZldUlSQnJFTHRabEp5Wld1M1F3WDAwQkNJLVlZMzRmcVZTQUhITFVVb3NxdGVTQW1IYTVjdjhGV0N0VnZIam9RMjEzVlR6djZKUkFKRnlzWFQ3MV9yell5Nm1QZGdHdlQyX1hMLTI0ZGExaVA2YmRRen…
AMIX Stock Rockets On Resale News As Dilution Risks Build - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxPQW5DZ2VQYWY3SGI5TDYwLU1GYmdKVGFoOXhrZGpocGdmTVE5T01OZW9FbTJpc2M4V3A1ekFYVDNiaGFfdWFqaTZqeVp5OUVQU1h2YmpQWmVDZzZueDhkVVRUWTk4NXZxSG1zcmhMeU9BRmJPZkFvX2NwWFBEYVlKSXJR?oc=5" target=…
Autonomix Medical, Inc. SEC Filing (Aug 5, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQQ2pYam9IRF9UYTJIbkNFTTdDMThHWDRPVGJBZm8wTU9TTG5kSHo3VFNPZHUzbWNselZzbHdLNFVPaDRsS25PZkQ1bFQ5MFhkdzc1cl9jY0puSjN6OUZmaEtiVlY5dlRFTXNzOEtySEpQTDQ1WklxWTZhaVgyQi1uXy1VeFlDelhHaXFLVm…
AMIX Stock Erupts As Dilution, Warrants Fuel Wild Volatility - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPVHBJdHYxUjJjZl9LZ3FCb25DelFFcnYtTE0xaTV1NXhfWUMzSUUtaU9INU1FNDNnZ2RYYmNFT3JxSXVWRHRpbmhpZ0t2VEpwRzR2MXFVRFhzZk9yT1lhUjhkS3BQc1g0Y2ZRX1Blc2dxSzhuelpaVEdtUmtONlg5Rw?oc=5" target="_…
Market Movers | Winners: AMIX, ADGM, IBTA | Losers: NXTT, AHCO, BETR - Trefis
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxPM1VwNGVzZFp0SVBfV29LVUplNFVIRmQ5RUQ1TVJ4cnU1YWVLbUNSX0lqbUJiV2FUQTIxR1dVZjl2bUlkSGN2enMzX1l1MVF0VFk2cTB0cjBaSVd4ejgtZjRINnBYMkRPdTJpbEZCTFo0amlNbkNqTWJua3NpRjNUbjcyeE5CU0tZQ3hKdn…
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxPMmNLajVqdmNLUURTZkx2bDVoN0s2ajJpQ2tsVFF1N05YVUNyS1VFTi1NZkNkb24xT3BiQnZWNWhVU25tdUlWUGtSeWlOSHVzUVVvQW4xeTFCa3EzcWZNMEdVZnZ5NjRDa2toQmVfTzNxX2xPYzlXTmlqeEUzYTZZQjNBc3lpRE1QejBXTm…
AMIX — Frequently Asked Questions
What is the current share price of AMIX?
As of 2026-08-05 17:25 PDT, AMIX trades at $12.10 on NASDAQ/NYSE. Its 52-week range is $2.75 to $28.14.
Is AMIX a good stock to buy?
This page provides a data-driven analysis of AMIX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.